The Emerging Era Of Nano-Pharmaceuticals

Pharmaceutical analysis may be defined as a procedure or the sequences of progressions to identify or quantify a constituent or drug, the mechanisms of a pharmaceutical solution or fusion or the determination of the structures of chemical combinations used in the formulation of pharmaceutical product. Pharmaceutical formulations that contain nano-sized drugs are perceived as “Nano-pharmaceuticals” or “Nano-theranostics” (i.e. billionth meter compounds potentially useful for diagnostics and therapeutics). The pharmaceutics/theranostics loaded into nanoparticles (NPs) can offer significant benefit for the patient compared to the conventional formulated drugs (i.e. drugs in their bulk-/free-form). Nevertheless, if the NPs are: (i) inappropriately prepared (e.g. inadequate surface properties); (ii) inaccurately dosed for in vivo delivery; (iii) environmentally uncontrolled/unmanaged and so, allow accidental or involuntary contact (e.g. skin exposure, inhalation, ingestion during the NPs production or use), they might then cause serious illnesses/health hazards like cardio-vascular diseases, neurological disorders as well as other effects similar to that reported with asbestos such as esothelioma and other lung-related conditions. In fact, it is important to know not only about the effect of NPs in a given body (e.g. human) but also have a clear picture about how this body is answering to the intrusion of NPs. This shall facilitate and strengthener our data interpretations about the efficacy and safety of the entity (e.g. drug compound) they contain.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024